SMS Pharmaceuticals Ltd

NSE: SMSPHARMA · BSE: 532815 · Pharmaceuticals & Biotechnology · 36 announcements

Share price: ₹523.55
Market cap: ₹4,641 Cr
Revenue (annual): ₹886.9 Cr
Net profit (annual): ₹102.0 Cr
P/E (TTM): 39.7×Sector 43.8×
Promoter holding: 68.07%+0.00% QoQ
FII holding: 1.18%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Legal & Regulatory 5 Financial Results 4 Earnings Call 4 Results Update 3 Board Meeting Date 3 Annual General Meeting 3 Other Announcement 2 Management Change 2 Price Movement Clarification 1 Dividend 1 Debt & Borrowing 1 Credit Rating 1 Capital Structure Change 1 Board Meeting Outcome 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

33 announcements with these filters

22 May 2026 13:48 IST BSE

Financial ResultsAlfa Alert

SMS Pharmaceuticals Q4 FY26 Results: Net Profit ₹32.7 Cr, Up 61.1% YoY

SMS Pharmaceuticals Ltd reported revenue from operations of ₹237.9 Cr (-4.1% YoY) and net profit of ₹32.7 Cr (+61.1% YoY) for Q4 FY26.

Key figure: Net profit ₹32.7 Cr · +61.1% YoY

Open full results → Read the filing ↗

22 May 2026 13:48 IST BSE

Financial Results

SMS Pharmaceuticals Financial Results

SMS Pharmaceuticals reported audited FY26 results and recommended a ₹0.40 per share final dividend. The company also approved shifting its registered office within Hyderabad.

Value: ₹0.40 Cr

Open announcement → Read the filing ↗

16 May 2026 10:37 IST NSE

Board Meeting Date

SMS Pharmaceuticals Board Meeting Date

SMS Pharmaceuticals scheduled a board meeting for May 22, 2026, to approve annual audited results and final dividend. Trading window remains closed until May 24, 2026.

Open announcement → Read the filing ↗